Literature DB >> 22814163

Gender differences in Kaposi's sarcoma-associated herpesvirus infection in a population with schistosomiasis in rural China.

Bishi Fu1, Rongge Yang, Fan Xia, Baolin Li, Xinxing Ouyang, Shou-Jiang Gao, Linding Wang.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causal agent of Kaposi's sarcoma (KS), a common cancer in patients with acquired immunodeficiency syndrome. The risk factors for KSHV infection have been extensively studied for Western countries but remain largely undefined for other parts of the world. Schistosomiasis, caused by Schistosoma japonicum infection, was recently identified as a cofactor for KSHV infection in rural Egypt. In this study, we examined the seroprevalence of KSHV in a population along the Yangtze River in China that has a high incidence of schistosomiasis. KSHV seroprevalence in subjects with schistosomiasis was slightly higher than that in subjects without schistosomiasis, but the difference was not statistically significant (8.4% versus 6.6%; P = 0.204). However, after adjusting for gender, KSHV seroprevalence in men with schistosomiasis was found to be significantly higher than that in men without schistosomiasis (8.4% versus 2.8%; odds ratio [OR], 3.170; 95% confidence interval [CI], 1.501-6.694; P = 0.002). Compared to men, women showed significantly higher seroprevalence of KSHV (5.9% versus 9.3%; OR, 1.621; 95% CI, 1.084-2.425; P = 0.019).

Entities:  

Mesh:

Year:  2012        PMID: 22814163      PMCID: PMC3513380          DOI: 10.7883/yoken.65.350

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  15 in total

1.  Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites.

Authors:  Mario Coluzzi; Maria Luisa Calabrò; Daniela Manno; Luigi Chieco-Bianchi; Thomas F Schulz; Valeria Ascoli
Journal:  J Infect Dis       Date:  2004-07-01       Impact factor: 5.226

2.  High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

Authors:  A Angeloni; L Heston; S Uccini; M C Sirianni; F Cottoni; M V Masala; D Cerimele; S F Lin; R Sun; M Rigsby; A Faggioni; G Miller
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

3.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas.

Authors:  J Baillargeon; J H Deng; E Hettler; C Harrison; J J Grady; L G Korte; J Alexander; E Montalvo; H B Jenson; S J Gao
Journal:  Ann Epidemiol       Date:  2001-10       Impact factor: 3.797

4.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

5.  Higher prevalence of human herpesvirus 8 DNA sequence and specific IgG antibodies in patients with pemphigus in China.

Authors:  Guan-Qing Wang; Honghui Xu; Ya-Kun Wang; Xing-Hua Gao; Yuming Zhao; Chundi He; Naoki Inoue; Hong-Duo Chen
Journal:  J Am Acad Dermatol       Date:  2005-03       Impact factor: 11.527

6.  Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.

Authors:  L Zhu; R Wang; A Sweat; E Goldstein; R Horvat; B Chandran
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

7.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa.

Authors:  D Wilkinson; J Sheldon; C F Gilks; T F Schulz
Journal:  S Afr Med J       Date:  1999-05

9.  Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily.

Authors:  A M Perna; F Bonura; F Vitale; E Viviano; M A Di Benedetto; F Ajello; M R Villafrate; T Prestileo; S Mancuso; J J Goedert; N Romano
Journal:  Int J Epidemiol       Date:  2000-02       Impact factor: 7.196

10.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

View more
  4 in total

1.  Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans.

Authors:  Fatma M Shebl; Benjamin Emmanuel; Lisa Bunts; Benon Biryahwaho; Christine Kiruthu; Meei-Li Huang; Ruth M Pfeiffer; Corey Casper; Sam M Mbulaiteye
Journal:  J Med Virol       Date:  2013-09       Impact factor: 2.327

Review 2.  Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Authors:  Lorin Begré; Eliane Rohner; Sam M Mbulaiteye; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2016-04-26       Impact factor: 7.396

3.  Prevalence and Risk Factors of Kaposi's Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China.

Authors:  Zhi Wen; Wenli Li; Yuan Fang; Chang Zhou; Kang Lin; Huanwu Wu; Yiting Zhang; Yulin Zhu; Xingchen Xu; Yan Zeng; Baojing Lu; Linding Wang
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-31       Impact factor: 2.471

4.  Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.

Authors:  Angela Nalwoga; Emily L Webb; Belinda Chihota; Wendell Miley; Bridgious Walusimbi; Jacent Nassuuna; Richard E Sanya; Gyaviira Nkurunungi; Nazzarena Labo; Alison M Elliott; Stephen Cose; Denise Whitby; Robert Newton
Journal:  PLoS Negl Trop Dis       Date:  2019-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.